Faron Pharmaceuticals - Innovatiivisia lääketieteen ratkaisuja (Osa 2)

When the failure to find a partner starts to slow down operations, it is obvious that the negotiators’ perceptions of becks’s value are nowhere near matching.

Time is far more valuable than a few tens of $M of friction regarding, for example, the size of the upfront payment.

It’s starting to look like a minor miracle if Bexnova starts on schedule in H1/2026. Blaze is already delayed.

12 Likes